MedPath

Improving Chronic Nocturnal Noninvasive Ventilation: a Multimodality Approach

Recruiting
Conditions
Chronic Respiratory Failure
Non-invasive Ventilation
Interventions
Device: Non-invasive ventilation
Registration Number
NCT05756387
Lead Sponsor
University Medical Center Groningen
Brief Summary

The aim of the data collection is to create an advanced reliable method to remotely monitor patient on chronic home non-invasive ventilation (NIV), both regarding ventilatory efficacy and patient comfort, both in the hospital and at home by assessing gas exchange, lung mechanics and the interaction between the patient and the ventilator.

For this purpose, we will set-up of databank of synchronously acquired datasets of already standard care monitored parameters during NIV (transcutaneous monitoring of gas exchange; ventilator data including data on PVA), and newly non-invasively acquired data on patient effort (EMG, patient ratings) and lung (hyper)inflation (EIT), during the set-up and follow-up of standard care chronic NIV.

Detailed Description

Can be provided on request as the registry rules are no in Dutch

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • COPD patients indicated for chronic home NIV
Exclusion Criteria
  • not able to read the written information and/or sign the informed consent form
  • no possibility to perfrom measurements at home

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
COPD patients with Chronic Respiratory FailureNon-invasive ventilation-
Primary Outcome Measures
NameTimeMethod
Sleep quality6 months

Sleep quality assessing sleep depth and sleep stages

Patient comfort6 months

Patient comfort assessed by VAS scale

AECOPD4 months

Acute exacerbations of COPD (defines as deterioration of symptoms requiring a course of/increase in Prednisolone dose and/or antibiotics)

Gas exchange6 months

Transcutaneous monitoring of gas exchange

Hospitalisations for AECOPD6 months

Hospitalisations for acute exacerbations of COPD

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UMCG

🇳🇱

Groningen, Netherlands

UMCG
🇳🇱Groningen, Netherlands
Marieke Duiverman, MD PhD
Contact
+31503613200
m.l.duiverman@umcg.nl
© Copyright 2025. All Rights Reserved by MedPath